BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Merus And Selexis SA Receive A € 2.1 Million Grant For Single Cell Line Manufacturing Of A Bispecific Antibody Combination To Treat Colorectal Cancer 5/20/2015 10:07:20 AM
Ligand Pharmaceuticals Inc. (LGND) Acquires Rights To More Than 15 Fully-Funded Development Programs From Selexis SA 5/11/2015 8:01:34 AM
Selexis SA Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 1/23/2015 11:34:16 AM
First Selexis SA SUREtechnology Generated Therapeutic Monoclonal Antibody Approved For Market 1/8/2015 11:11:41 AM
Symphogen A/S Licenses The Selexis SA SUREtechnology Expression Platform And Cell Line 12/9/2014 11:29:21 AM
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014 10:13:58 AM
Selexis SA To Showcase Revolutionary Advancements In Protein Expression Technologies At BIO 2014 6/5/2014 9:17:00 AM
Opthea Signs Cell Line Development Commercial License Agreement With Selexis SA For Wet AMD Product 1/14/2014 10:40:35 AM
Ligand Pharmaceuticals Inc. (LGND) Buys Rights to Programs From Selexis SA 4/30/2013 7:32:13 AM
Selexis SA Announces Expansion of R&D License Agreement With Amgen (AMGN) 2/20/2013 10:25:23 AM
1234